Autologous hematopoietic stem cell transplantation (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 84 | サルコイドーシス | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00282438 (ClinicalTrials.gov) | December 2003 | 24/1/2006 | Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis | Hematopoietic Stem Cell Transplant in Patients With Refractory Sarcoidosis: A Phase I/II Trial | Sarcoidosis | Biological: Autologous hematopoietic stem cell transplantation;Biological: Allogeneic stem cell transplantation | Northwestern University | NULL | Terminated | 18 Years | 60 Years | All | 2 | Phase 1;Phase 2 | United States |